Cargando…

Transcatheter mitral valve replacement for degenerated mitral valve bioprostheses, failure of mitral valvuloplasty and native valve with severe mitral annulus calcification: a systematic review and meta-analysis

BACKGROUND: Although transcatheter technology has achieved some success in the field of mitral valves, the feasibility of applying it to patients with degenerated mitral valve bioprostheses (valve-in-valve, ViV), failure of mitral valvuloplasty (valve-in-ring, ViR) and serious mitral annulus calcifi...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Tao, Wang, Wei, Yi, Kang, Gao, Jie, Zhang, Xin, He, Shao-E., Xu, Xiao-Min, Ma, Yu-Hu, Li, Xin-Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504093/
https://www.ncbi.nlm.nih.gov/pubmed/34629106
http://dx.doi.org/10.1186/s13019-021-01677-7
_version_ 1784581261840351232
author You, Tao
Wang, Wei
Yi, Kang
Gao, Jie
Zhang, Xin
He, Shao-E.
Xu, Xiao-Min
Ma, Yu-Hu
Li, Xin-Yao
author_facet You, Tao
Wang, Wei
Yi, Kang
Gao, Jie
Zhang, Xin
He, Shao-E.
Xu, Xiao-Min
Ma, Yu-Hu
Li, Xin-Yao
author_sort You, Tao
collection PubMed
description BACKGROUND: Although transcatheter technology has achieved some success in the field of mitral valves, the feasibility of applying it to patients with degenerated mitral valve bioprostheses (valve-in-valve, ViV), failure of mitral valvuloplasty (valve-in-ring, ViR) and serious mitral annulus calcification (vale-in-MAC, ViMAC) has not been effectively evaluated. METHODS: By searching published literature before December 5, 2020 in four databases, we found all the literature related to the evaluation of feasibility assessment of TMViV, TMViR and TMViMAC. Outcomes focused on all-cause mortality within 30 days, bleeding and LVOT obstruction. RESULTS: A total of six studies were included, and all of them were followed up for at least 30 days. After analysis of the ViV–ViR group, we obtained the following results: the all-cause mortality within 30 days of the ViV group was lower than that of the ViR group. Life-threatening or fatal bleeding was more likely to occur in the ViR group after surgery. At the same time, the ViR group was more prone to left ventricular outflow tract obstruction. However, in the ViMAC–ViR group, only the all-cause mortality within 30 days and stroke were statistically significant. In the indirect comparison, we found that TMViV had the best applicability, followed by TMViR. There were few TMViMAC available for analysis, and it requires further studies to improve the accuracy of the results. CONCLUSION: TMViV and TMViR had good applicability and could benefit patients who underwent repeat valve surgery. The feasibility of TMViMAC needs to be further explored and improved. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13019-021-01677-7.
format Online
Article
Text
id pubmed-8504093
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85040932021-10-25 Transcatheter mitral valve replacement for degenerated mitral valve bioprostheses, failure of mitral valvuloplasty and native valve with severe mitral annulus calcification: a systematic review and meta-analysis You, Tao Wang, Wei Yi, Kang Gao, Jie Zhang, Xin He, Shao-E. Xu, Xiao-Min Ma, Yu-Hu Li, Xin-Yao J Cardiothorac Surg Research Article BACKGROUND: Although transcatheter technology has achieved some success in the field of mitral valves, the feasibility of applying it to patients with degenerated mitral valve bioprostheses (valve-in-valve, ViV), failure of mitral valvuloplasty (valve-in-ring, ViR) and serious mitral annulus calcification (vale-in-MAC, ViMAC) has not been effectively evaluated. METHODS: By searching published literature before December 5, 2020 in four databases, we found all the literature related to the evaluation of feasibility assessment of TMViV, TMViR and TMViMAC. Outcomes focused on all-cause mortality within 30 days, bleeding and LVOT obstruction. RESULTS: A total of six studies were included, and all of them were followed up for at least 30 days. After analysis of the ViV–ViR group, we obtained the following results: the all-cause mortality within 30 days of the ViV group was lower than that of the ViR group. Life-threatening or fatal bleeding was more likely to occur in the ViR group after surgery. At the same time, the ViR group was more prone to left ventricular outflow tract obstruction. However, in the ViMAC–ViR group, only the all-cause mortality within 30 days and stroke were statistically significant. In the indirect comparison, we found that TMViV had the best applicability, followed by TMViR. There were few TMViMAC available for analysis, and it requires further studies to improve the accuracy of the results. CONCLUSION: TMViV and TMViR had good applicability and could benefit patients who underwent repeat valve surgery. The feasibility of TMViMAC needs to be further explored and improved. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13019-021-01677-7. BioMed Central 2021-10-10 /pmc/articles/PMC8504093/ /pubmed/34629106 http://dx.doi.org/10.1186/s13019-021-01677-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
You, Tao
Wang, Wei
Yi, Kang
Gao, Jie
Zhang, Xin
He, Shao-E.
Xu, Xiao-Min
Ma, Yu-Hu
Li, Xin-Yao
Transcatheter mitral valve replacement for degenerated mitral valve bioprostheses, failure of mitral valvuloplasty and native valve with severe mitral annulus calcification: a systematic review and meta-analysis
title Transcatheter mitral valve replacement for degenerated mitral valve bioprostheses, failure of mitral valvuloplasty and native valve with severe mitral annulus calcification: a systematic review and meta-analysis
title_full Transcatheter mitral valve replacement for degenerated mitral valve bioprostheses, failure of mitral valvuloplasty and native valve with severe mitral annulus calcification: a systematic review and meta-analysis
title_fullStr Transcatheter mitral valve replacement for degenerated mitral valve bioprostheses, failure of mitral valvuloplasty and native valve with severe mitral annulus calcification: a systematic review and meta-analysis
title_full_unstemmed Transcatheter mitral valve replacement for degenerated mitral valve bioprostheses, failure of mitral valvuloplasty and native valve with severe mitral annulus calcification: a systematic review and meta-analysis
title_short Transcatheter mitral valve replacement for degenerated mitral valve bioprostheses, failure of mitral valvuloplasty and native valve with severe mitral annulus calcification: a systematic review and meta-analysis
title_sort transcatheter mitral valve replacement for degenerated mitral valve bioprostheses, failure of mitral valvuloplasty and native valve with severe mitral annulus calcification: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504093/
https://www.ncbi.nlm.nih.gov/pubmed/34629106
http://dx.doi.org/10.1186/s13019-021-01677-7
work_keys_str_mv AT youtao transcathetermitralvalvereplacementfordegeneratedmitralvalvebioprosthesesfailureofmitralvalvuloplastyandnativevalvewithseveremitralannuluscalcificationasystematicreviewandmetaanalysis
AT wangwei transcathetermitralvalvereplacementfordegeneratedmitralvalvebioprosthesesfailureofmitralvalvuloplastyandnativevalvewithseveremitralannuluscalcificationasystematicreviewandmetaanalysis
AT yikang transcathetermitralvalvereplacementfordegeneratedmitralvalvebioprosthesesfailureofmitralvalvuloplastyandnativevalvewithseveremitralannuluscalcificationasystematicreviewandmetaanalysis
AT gaojie transcathetermitralvalvereplacementfordegeneratedmitralvalvebioprosthesesfailureofmitralvalvuloplastyandnativevalvewithseveremitralannuluscalcificationasystematicreviewandmetaanalysis
AT zhangxin transcathetermitralvalvereplacementfordegeneratedmitralvalvebioprosthesesfailureofmitralvalvuloplastyandnativevalvewithseveremitralannuluscalcificationasystematicreviewandmetaanalysis
AT heshaoe transcathetermitralvalvereplacementfordegeneratedmitralvalvebioprosthesesfailureofmitralvalvuloplastyandnativevalvewithseveremitralannuluscalcificationasystematicreviewandmetaanalysis
AT xuxiaomin transcathetermitralvalvereplacementfordegeneratedmitralvalvebioprosthesesfailureofmitralvalvuloplastyandnativevalvewithseveremitralannuluscalcificationasystematicreviewandmetaanalysis
AT mayuhu transcathetermitralvalvereplacementfordegeneratedmitralvalvebioprosthesesfailureofmitralvalvuloplastyandnativevalvewithseveremitralannuluscalcificationasystematicreviewandmetaanalysis
AT lixinyao transcathetermitralvalvereplacementfordegeneratedmitralvalvebioprosthesesfailureofmitralvalvuloplastyandnativevalvewithseveremitralannuluscalcificationasystematicreviewandmetaanalysis